Illumicell AI utilizes patented AI algorithms and proprietary microscopy technology to deliver fertility diagnostics at the point of care, achieving testing speeds 50 times faster and effectiveness 20 times greater than traditional methods. This technology enables healthcare providers, beyond just fertility clinics, to access scalable and efficient diagnostic solutions, addressing the need for timely and accurate fertility assessments.
Funding
$300K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BAKHFounders
Product
Problem
Traditional fertility diagnostics often rely on centralized labs, leading to delays in obtaining results and limiting accessibility for patients in remote areas or those seeking immediate insights. Existing methods can also be time-consuming and may not provide the comprehensive analysis needed for effective fertility management.
Solution
Illumicell AI offers a point-of-care fertility diagnostic solution that leverages artificial intelligence and advanced microscopy to accelerate and enhance the assessment process. Their technology enables healthcare providers to perform rapid and accurate fertility assessments directly in their clinics or at the patient's location. By integrating AI-powered image analysis with proprietary microscopy, Illumicell AI aims to provide faster results and more comprehensive data compared to conventional lab-based methods. This approach facilitates timely decision-making and personalized treatment plans, ultimately improving patient outcomes and streamlining clinical workflows. The system is designed to be scalable and accessible, expanding the reach of advanced fertility diagnostics beyond specialized fertility centers.
Target Audience
The primary target audience includes healthcare providers such as fertility clinics, OB/GYN practices, and hospitals seeking to improve the speed, accuracy, and accessibility of fertility diagnostics.
Features
- AI-powered image analysis for rapid assessment of fertility indicators
- Proprietary microscopy technology for high-resolution imaging
- Point-of-care testing capabilities for immediate results
- Streamlined workflow for efficient clinical operations
- Scalable solution for diverse healthcare settings